Castle Biosciences Inc (CSTL)
29.81
+0.93
(+3.22%)
USD |
NASDAQ |
Nov 22, 16:00
29.81
0.00 (0.00%)
After-Hours: 20:00
Castle Biosciences Total Assets (Quarterly): 514.56M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 514.56M |
| June 30, 2024 | 487.31M |
| March 31, 2024 | 458.51M |
| December 31, 2023 | 453.34M |
| September 30, 2023 | 436.02M |
| June 30, 2023 | 425.40M |
| March 31, 2023 | 426.89M |
| December 31, 2022 | 447.33M |
| September 30, 2022 | 457.81M |
| June 30, 2022 | 458.38M |
| March 31, 2022 | 444.42M |
| December 31, 2021 | 462.57M |
| Date | Value |
|---|---|
| September 30, 2021 | 433.69M |
| June 30, 2021 | 435.53M |
| March 31, 2021 | 437.33M |
| December 31, 2020 | 439.33M |
| September 30, 2020 | 210.39M |
| June 30, 2020 | 201.55M |
| March 31, 2020 | 120.26M |
| December 31, 2019 | 119.75M |
| September 30, 2019 | 113.20M |
| June 30, 2019 | 33.35M |
| March 31, 2019 | 30.97M |
| December 31, 2018 | 22.40M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
119.75M
Minimum
Dec 2019
514.56M
Maximum
Sep 2024
393.52M
Average
438.33M
Median
Total Assets (Quarterly) Benchmarks
| Delcath Systems Inc | 31.68M |
| Star Equity Holdings Inc | 85.72M |
| Exact Sciences Corp | 6.749B |
| CytoSorbents Corp | 47.80M |
| Progyny Inc | 659.97M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 73.51M |
| Shareholders Equity (Quarterly) | 441.06M |
| Debt to Equity Ratio | 0.0227 |
| Current Ratio | 7.784 |
| Net Debt Paydown Yield | -0.25% |